Asthma and Allergic Diseases Cooperative Research Centers (U19 Clinical Trial Optional)
National Institutes of Health (NIH)
Total budget of $6.08 million for FY 2026
Funding for 4-5 awards
To support centers that integrate clinical and translational research on asthma and allergic diseases.
To improve understanding of the pathogenesis of these conditions and develop effective treatments and prevention strategies.
Researchers and healthcare providers
Patients affected by asthma and allergic diseases
The broader public through improved health outcomes
Eligible organizations include higher education institutions, public/state controlled institutions, private institutions of higher education, nonprofits, for-profit organizations, local and state governments, and Indian/Native American tribal governments.
Institutions with active AADCRC awards funded under RFA-AI-21-079 are not eligible to apply.
Only one application per institution is allowed.
U.S. organizations are eligible; non-domestic (non-U.S.) entities are not eligible to apply.
Foreign components of U.S. organizations are allowed under certain conditions.
Research must focus on asthma, rhinitis, chronic rhinosinusitis, atopic dermatitis, food allergy, and drug allergy.
The majority of proposed research must be defined as human subjects research or utilize human material.
Application budgets are not expected to exceed $900,000 in direct costs per year.
Infrastructure Opportunity Fund (IOF) budget is not expected to exceed $350,000 in direct costs per year.
Applications are due by June 13, 2025.
Open date for submissions is May 13, 2025.
Institutions with active AADCRC awards funded under RFA-AI-21-079 are not eligible to apply.
Applications must follow the Multi-Project Instructions in the How to Apply - Application Guide.
Applications will be evaluated for scientific and technical merit through the NIH peer review system.
Applications will undergo a two-level review process: scientific peer review and advisory council review.
Overall impact, significance, investigator qualifications, innovation, approach, and environment will be considered.
The program encourages multidisciplinary research and collaboration among institutions.
Limited funding may restrict the number of applications that can be awarded.
Research should align with NIH priorities in asthma and allergic diseases.
Institutions with prior experience in NIH-funded research may have an advantage.
Strong collaboration among researchers and institutions.
Submitting overlapping applications from the same institution.
Engage with NIH contacts early in the application process.
Highlight unique institutional strengths and collaborative opportunities in the application.